HealthUS regulators back multi-cancer blood test, but Hong Kong doctors remain cautious
US regulators have endorsed technology designed to detect multiple cancers from a single blood draw for the first time. An FDA panel voted in favour of Grail’s Galleri test, but experts say wider use in Hong Kong still faces hurdles as doctors question its clinical value.
S
South China Morning Post★★★☆☆2026-09-24 10:05Original
US regulators back multi-cancer blood test, but Hong Kong doctors remain cautious
Health